Biovaxys Technology

Biovaxys Technology EBIT per Share

The EBIT per Share of Biovaxys Technology (BIOV.CN) as of Oct 13, 2026 is -0.13 CAD. In the previous year, EBIT per Share was -0.44 CAD — a change of -71.72% (higher).

EBIT per Share

-0.13CAD

YoY

-71.72%

Last updated:

EBIT per Share of Biovaxys Technology is 2024 -0.13 CAD. EBIT per Share of Biovaxys Technology was 2023 -0.44 CAD. It decreases by -71.72% higher compared to the previous year.

The Biovaxys Technology EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.08 CAD
Jan 1, 2019
-0.01 CAD
Jan 1, 2020
-0.01 CAD
Jan 1, 2021
-0.07 CAD
Jan 1, 2022
-0.04 CAD
Jan 1, 2023
-0.44 CAD
Jan 1, 2024
-0.13 CAD
The Biovaxys Technology EBIT per Share history
YEAREBIT per ShareYoY
-0.13CAD-71.72%
-0.44CAD+1,085.50%
-0.04CAD-46.32%
-0.07CAD+371.27%
-0.01CAD+38.37%
-0.01CAD-86.03%
-0.08CAD—
Access this data via the Eulerpool API
Get Free API Key

Biovaxys Technology Stock analysis

What does Biovaxys Technology do? Biovaxys Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biovaxys Technology stock

EBIT per Share of Biovaxys Technology is -0.13 CAD in 2024.

EBIT per Share of Biovaxys Technology changed from -0.44 CAD to -0.13 CAD, representing a -71.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Biovaxys Technology since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Biovaxys Technology

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Biovaxys Technology